AstraZeneca isn’t letting a…
AstraZeneca isn’t letting a death in a China trial detract [...]
Otsuka Pharmaceutical has acquired…
Otsuka Pharmaceutical has acquired Transcend Therapeutics for $700 million upfront [...]
Takeda has posted phase 3 data on…
Takeda has posted phase 3 data on an autoimmune asset [...]
AstraZeneca’s chronic…
AstraZeneca’s chronic obstructive pulmonary disease drug candidate has hit the [...]
Novartis has penned a $2 billion…
Novartis has penned a $2 billion deal for a biotech [...]
Seasoned biotech takeover titan…
Seasoned biotech takeover titan Kevin Tang has struck again. After [...]
Pulmatrix may have been discarded…
Pulmatrix may have been discarded by Cullgen, but the inhaled [...]
Oral peptide specialist Pinnacle…
Oral peptide specialist Pinnacle Medicines has secured an $89 million [...]
John Stanford spent a busy day on…
John Stanford spent a busy day on Capitol Hill this [...]
Wave Life Sciences linked its…
Wave Life Sciences linked its obesity drug candidate to a [...]